Health CanadaGeneral Alert
Desmopressin nasal sprays (including Apo-Desmopressin Spray) are associated with...
Published: August 6, 2008Recall ID: 24371Category: generalCountry: Canada
Product Description & Identification
Desmopressin nasal sprays (including Apo-Desmopressin Spray) are associated with an increased risk of serious side effects involving water retention and decreased blood sodium levels (hyponatremia). - For Health Professionals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24371 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/desmopressin-nasal-sprays-including-apo-desmopressin-spray-are-associated-increased |
| Title | Desmopressin nasal sprays (including Apo-Desmopressin Spray) are associated with an increased risk of serious side effects involving water retention and decreased blood sodium levels (hyponatremia). - For Health Professionals |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2008-08-06 |
| Organization | Marketed health products |